Clinical Trial Update: HD Melphalan and SCT in Patients With IGDD or LCDD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose melphalan with autologous stem cell transplant in patients with multiple myeloma, including those with IGDD or LCDD; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Boston Medical Center | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2017-03-15